SCHEMBL6158520

SCHEMBL6158520

Cc1ccc(S(=O)(=O)N(c2ccccc2)c2ccc(CO)cc2)cc1

nearest known ligand 0.61

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.61
ESR1 P03372 1/20 0.55
PKM P14618 1/20 0.54
CA12 O43570 1/20 0.54
CA9 Q16790 1/20 0.54
CNR2 P34972 6/20 0.53
CNR1 P21554 3/20 0.53
NR1I2 O75469 1/20 0.50
PTGES O14684 1/20 0.49
ALOX5 P09917 1/20 0.49
TAS2R14 Q9NYV8 1/20 0.49
KEAP1 Q14145 2/20 0.49
NFE2L2 Q16236 2/20 0.49
KMT2A Q03164 1/20 0.47
NR3C1 P04150 1/20 0.47
LMNA P02545 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3697451 0.86 PKM (0.71) ALDH1A1ESR1PKMCA12CA9
SCHEMBL6158969 0.85 ALDH1A1 (0.58) ALDH1A1ESR1PKMCA12CA9
SCHEMBL28634601 0.84 ALDH1A1 (0.66) ALDH1A1ESR1PKMCA12CA9
SCHEMBL3702995 0.82 ALDH1A1 (0.63) ALDH1A1ESR1PKMCA12CA9
SCHEMBL3701001 0.80 MAPT (0.67) ALDH1A1ESR1PKMCA12CA9
SCHEMBL3886338 0.80 ALDH1A1 (0.62) ALDH1A1ESR1PKMCA12CA9
SCHEMBL6158839 0.78 ALDH1A1 (0.59) ALDH1A1ESR1PKMCA12CA9
SCHEMBL14467764 0.77 CYP2C19 (0.48) ALDH1A1CNR2CNR1NR1I2KMT2A
SCHEMBL28380035 0.77 NPSR1 (0.69) ALDH1A1ESR1PKMCA12CA9
SCHEMBL6157398 0.77 ALDH1A1 (0.58) ALDH1A1ESR1PKMCA12CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6953789-B2 Thiol compounds, their production and use TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2005-10-11 US disclosed
US-20040157894-A1 Thiol compounds, their production and use TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-08-12 US disclosed
US-6699881-B2 MATRIX METALLOPROTEASE INHIBITORS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2004-03-02 US disclosed
US-20030078253-A1 Thiol compounds, their production and use TAKEDA PHARMACEUTICAL COMPANY, LIMITED (JP) 2003-04-24 US disclosed
US-6420415-B1 Thiol compounds, their production and use TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2002-07-16 US disclosed
EP-1132379-A1 NOVEL THIOL DERIVATIVES, PROCESS FOR PRODUCING THE SAME AND UTILIZATION THEREOF Takeda Chemical Industries, Ltd. (JP) 2001-09-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030078253-A1 Thiol compounds, their production and use TST, QSOX1, SULT1E1 ALDH1A1 905/4885ESR1 2080/4885PKM 4604/4885
US-20040157894-A1 Thiol compounds, their production and use TST, SULT1E1, QSOX1 ALDH1A1 877/4885ESR1 1792/4885PKM 4525/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.